![Pharmaceuticals | Free Full-Text | Possible Antidepressant Effects of Memantine—Systematic Review with a Case Study Pharmaceuticals | Free Full-Text | Possible Antidepressant Effects of Memantine—Systematic Review with a Case Study](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-14-00481/article_deploy/html/images/pharmaceuticals-14-00481-g001.png?1621405965)
Pharmaceuticals | Free Full-Text | Possible Antidepressant Effects of Memantine—Systematic Review with a Case Study
![PDF] Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias | Semantic Scholar PDF] Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/af3de39a1e8e30e82aeed4daa0ef8f82ae25bb1b/7-Table2-1.png)
PDF] Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias | Semantic Scholar
![Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine | Journal of Neuroscience Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/29/9/2774/F1.large.jpg)
Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine | Journal of Neuroscience
![Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse - ScienceDirect Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0028390807002298-gr1.jpg)
Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse - ScienceDirect
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
![Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease | SpringerLink Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12640-013-9398-z/MediaObjects/12640_2013_9398_Fig2_HTML.gif)
Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease | SpringerLink
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
![Recent Advances in Alzheimer's Disease in Relation to Cholinesterase Inhibitors and NMDA Receptor Antagonists | SpringerLink Recent Advances in Alzheimer's Disease in Relation to Cholinesterase Inhibitors and NMDA Receptor Antagonists | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-981-16-4558-7_8/MediaObjects/494450_1_En_8_Fig2_HTML.png)
Recent Advances in Alzheimer's Disease in Relation to Cholinesterase Inhibitors and NMDA Receptor Antagonists | SpringerLink
![The '3-neurone model' for the action of memantine and the AChEIs in AD | Download Scientific Diagram The '3-neurone model' for the action of memantine and the AChEIs in AD | Download Scientific Diagram](https://www.researchgate.net/profile/Chris-Parsons-12/publication/236666023/figure/fig2/AS:202632124735503@1425322671854/The-3-neurone-model-for-the-action-of-memantine-and-the-AChEIs-in-AD_Q640.jpg)